Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PMVP

PMV Pharmaceuticals Inc

Jun 10 • 04:00PM ET

1.06

+0.01 0.95 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ANIX ANVS COYA CYPH EXOZ FBIO ICCC MCRB PLRX XBIT

| Held by: VTI VXF IWC BTEC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	8.32%	Shs Outstand	53.33M	Perf Week	-8.62%
Market Cap	56.53M	Forward P/E	-	EPS next Y	-1.12	Insider Trans	0.00%	Shs Float	48.90M	Perf Month	-23.74%
Enterprise Value	-36.73M	PEG	-	EPS next Q	-0.40	Inst Own	64.41%	Short Float	6.66%	Perf Quarter	-33.75%
Income	-78.34M	P/S	-	EPS this Y	1.13%	Inst Trans	-2.52%	Short Ratio	8.27	Perf Half Y	-9.40%
Sales	0.00M	P/B	0.64	EPS next Y	23.69%	ROA	-58.65%	Short Interest	3.26M	Perf YTD	-15.20%
Book/sh	1.65	P/C	0.60	EPS next 5Y	13.14%	ROE	-63.16%	52W High	1.88 -43.62%	Perf Year	-10.92%
Cash/sh	1.75	P/FCF	-	EPS past 3/5Y	2.74% -13.98%	ROIC	-89.06%	52W Low	0.96 9.94%	Perf 3Y	-80.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.86% 5.86%	Perf 5Y	-96.76%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-26.14%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	30.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.14	EPS Q/Q	-0.77%	SMA20	-12.47%	Beta	1.37	Target Price	4.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-19.37%	Rel Volume	0.38	Prev Close	1.05
Employees	54	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-19.58%	Avg Volume	393.58K	Price	1.06
IPO	Sep 25, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% -	Trades		Volume	150,574	Change	0.95%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)